The diplomatic stand-off between India and Canada is unlikely to have any impact on the pharmaceutical exports, according to R Uday Bhaskar, Director-General, Pharmaceutical Export Promotion Council.“Going by the current state of affairs, I do not think any adverse impact is possible. Canada is the second biggest market in North America after the US for pharma exports and therefore, it is an important geography for our pharma industry,’‘ he told businessline.
Growing exports
Indian pharma exports to Canada grew 21 percent at $506 million in FY23 compared to the previous financial year....
The diplomatic stand-off between India and Canada is unlikely to have any impact on the pharmaceutical exports, according to R Uday Bhaskar, Director-General, Pharmaceutical...
Chennai-based Caplin Point Laboratories has earmarked ₹500-550 crore towards capital expenditure (capex). It includes expansion of existing capacities, additional manufacturing sites to widen...